Notch and TGFβ Form a Reciprocal Positive Regulatory Loop that Suppresses Murine Prostate Basal Stem/Progenitor Cell Activity  by Valdez, Joseph M. et al.
Cell Stem Cell
ArticleNotch and TGFb Form a Reciprocal Positive
Regulatory Loop that Suppresses Murine
Prostate Basal Stem/Progenitor Cell Activity
Joseph M. Valdez,1 Li Zhang,1 Qingtai Su,1 Olga Dakhova,2 Yiqun Zhang,3 Payam Shahi,2,3 David M. Spencer,2,3
Chad J. Creighton,3 Michael M. Ittmann,2,3 and Li Xin1,2,3,*
1Department of Molecular and Cellular Biology
2Department of Pathology and Immunology
3Dan L. Duncan Cancer Center
Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
*Correspondence: xin@bcm.edu
http://dx.doi.org/10.1016/j.stem.2012.07.003SUMMARY
The role of Notch signaling in the maintenance of
adult murine prostate epithelial homeostasis remains
unclear. We found that Notch ligands are mainly ex-
pressed within the basal cell lineage, while active
Notch signaling is detected in both the prostate basal
and luminal cell lineages. Disrupting the canonical
Notch effector Rbp-j impairs the differentiation of
prostate basal stem cells and increases their prolifer-
ation in vitro and in vivo, but does not affect luminal
cell biology. Conversely, ectopic Notch activation in
adult prostates results in a decrease in basal cell
number and luminal cell hyperproliferation. TGFb
dominates over Notch signaling and overrides Notch
ablation-induced proliferation of prostate basal
cells. However, Notch confers sensitivity and posi-
tive feedback by upregulating a plethora of TGFb
signaling components including TgfbR1. These find-
ings reveal crucial roles of the self-enforced positive
reciprocal regulatory loop between TGFb and Notch
in maintaining prostate basal stem cell dormancy.
INTRODUCTION
The Notch pathway is evolutionarily conserved and is crucial for
the proper development and homeostasis of a number of tissues
in multicellular species (Kopan and Ilagan, 2009). Canonical
Notch signaling involves activation of the Notch transmembrane
receptor (Notch1–4 in mammals) by the binding of one of its
ligands (Dll1/3/4 and Jagged1/2 in mammals), which are ex-
pressed on the cell surface of adjacent cells. Upon binding,
Notch receptor is sequentially cleaved by an ADAM family metal-
loprotease and the g-Secretase complex, resulting in the release
of the Notch intracellular domain (NICD). NICD translocates into
the nucleus and binds the transcription factor RBP-J, releasing
repressive cofactors and recruiting transcription machinery to
activate RBP-J target genes.
Notch plays a complicated role during organogenesis and
tissue homeostasis (Chiba, 2006). Notch activation increases676 Cell Stem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Inthe self-renewal capacity of hematopoietic, neural, and muscle
stem cells (Androutsellis-Theotokis et al., 2006; Conboy et al.,
2003; Duncan et al., 2005), but induces differentiation of stem
cells in skin and breast (Bouras et al., 2008; Okuyama et al.,
2004). To add to the complexity, the biological consequence of
Notch activation can be distinct at different developmental
stages. For example, Notch activation suppresses the differenti-
ation of murine intestinal stem cells in embryos, but inhibits
secretory fates of intestinal stem cells in the adult (Stanger
et al., 2005).
The majority of Notch-related studies in the prostate focused
on its function during embryonic and neonatal stages. Develop-
mentally, the prostate originates from a hindgut-derived endo-
dermal tube termed urogenital sinus (UGS) (Staack et al.,
2003). Prostatic morphogenesis starts at E17 in mice when the
UGS epithelia (UGSE) protrude into the surrounding mesen-
chyme. The UGSE cells are the putative embryonic prostate
epithelial stem cells and express both Keratin 5 (K5) and
Keratin 8 (K8). Subsequently, the UGSE modules canalize to
form lumens. UGSE cells undergo lineage commitment by selec-
tively losing one of the keratins to form K8-expressing luminal
cells surrounding the lumen and K5-expressing basal cells that
reside between the basement membrane and luminal cells
(Wang et al., 2001). Pharmacological suppression of Notch
signaling in in vitro cultured UGS inhibits UGSE differentiation
and blocks basal and luminal cell lineage commitment (Orr
et al., 2009; Wang et al., 2006). Similar conclusions were made
when Notch1 was ablated in neonatal prostate tissues (Wang
et al., 2006). In another study, disrupting Rbp-j in embryonic
prostate epithelial cells caused defects in epithelial stratification
and a reduction in basal cell number (Wu et al., 2011).
The function of Notch in adult prostate epithelial homeostasis
has not been as well characterized. Studies in recent years
demonstrated that adult prostate basal and luminal cells are
mainly self-sustained independently in vivo, but basal cells
display prominent multipotent stem cell activity in a transplanta-
tion-based regeneration assay (Burger et al., 2005; Choi et al.,
2012; Lawson et al., 2007; Goldstein et al., 2008). Notch1-
expressing cells are indispensable for functional regeneration
of adult prostate, which implies a potential role for Notch sig-
naling in the regenerative capacity of prostate epithelia (Wang
et al., 2004). We previously showed that Wnt signaling inducesc.
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signaling (Shahi et al., 2011). Ectopic Notch activation has also
been shown to result in a benign prostate hyperplasia phenotype
in vivo (Wu et al., 2011). However, the expression pattern of
Notch signaling components and the functional role of Notch in
different prostate epithelial lineages in adults still remain
understudied.
Prostate epithelial cells turn over very slowly. The quiescence
of prostate epithelia is the overall net outcome of a variety of
signaling networks that are often regulated by stromal-epithelial
interactions (Marker et al., 2003). Among those signaling
networks, TGFb is one of the most extensively investigated
signal transduction pathways. TGFb has been shown to play
a critical role inmaintaining prostatic basal stem cell quiescence.
Prostatic stem cells are enriched in the proximal region of the
prostate that is anatomically adjacent to the urethra (Burger
et al., 2005; Lawson et al., 2007). A large band of smooth muscle
that secretes high levels of TGFb envelops this proximal region
(Nemeth and Lee, 1996). Salm et al. have shown that TGFb
can inhibit the proliferation of prostatic epithelial cells, and that
the concentration and activity of TGFb is higher in the proximal
region, which contributes to the replicative quiescent nature of
prostate stem cells (Salm et al., 2005). TGFb signaling has
been specifically disrupted in prostate epithelia. Surprisingly,
no distinctive changes in cellular proliferation were observed
when TGFbR2 (Placencio et al., 2008) or SMAD4 (Ding et al.,
2011) were ablated in the prostate, while only a very mild
increase in prostate epithelial proliferation was reported when
a dominant-negative TGFbR2was ectopically expressed (Kundu
et al., 2000). This implies the existence of other signaling path-
ways that are redundant to TGFb, among which Notch is one
(Kluppel and Wrana, 2005). This study aims to investigate the
role of Notch in adult prostate epithelial maintenance and differ-
entiation, and to unveil howNotch and TGFb coordinate together
to regulate these biological processes.
RESULTS
Expression of Notch Signaling Components in Prostate
Epithelium
To gain insight into how Notch signaling is activated in the pros-
tate, we determined the expression pattern of a comprehensive
collection of Notch signaling components in prostate basal and
luminal cell lineages by quantitative reverse transcriptase-
polymerase chain reaction (qRT-PCR) analysis. Individual adult
murine prostate cell lineages were separated by fluorescence-
activated cell sorting (FACS) based on their surface antigenic
expression profiles as described previously (Lawson et al.,
2007) (Figure 1A). qRT-PCR analyses showed that transcripts
for the basal cell marker P63, the luminal cell marker Nkx3.1,
and the stromal cell marker Vimentin were enriched in their
corresponding cell fractions, demonstrating successful cell frac-
tionation (Figure 1B).
A pathway-focused PCR array was utilized to determine the
expression of 84 Notch-signaling-related genes in the prostate
basal and luminal epithelial cell lineages (Figure 1C). Notch1
and Notch2 are the most highly expressed receptors in both
prostate basal and luminal cells. Jagged1 (Jag1) is the most
highly expressed Notch ligand and is highly enriched in basalCellcells. Interestingly, although Dll1 and Jag2 were expressed at
lower levels, they are also preferentially expressed in basal cells.
Dll3 and Dll4 were undetectable (data not shown). Notch pro-
cessing components such as ADAM metalloproteases and
g-Secretase complex members, as well as signal modulators
such as Numb, NCoR2, and the Fringe family members, were
widely expressed in both cell lineages. Lastly, downstream
canonical Notch target genes Hes1, Hey1, and HeyL and the
transcription factor Rbp-j were expressed in both basal and
luminal compartments. Collectively, these results suggest that
Notch signaling is active in at least a fraction of cells in both basal
and luminal epithelial cells of the prostate, and that basal cells
express ligands that may activate Notch signaling in adjacent
basal and luminal cells.
Loss of Notch Signaling Induces Basal Cell Expansion
during Regeneration
To investigate whether Notch signaling plays a role in the main-
tenance of adult murine prostate epithelial homeostasis, we
ablated Notch signaling specifically in the prostate by breeding
Rbp-jf/f mice (Han et al., 2002) (hereafter referred to as WT
mice) with ARR2PB-Cre mice (Jin et al., 2003) to generate
ARR2PB-Cre; Rbp-J f/f mice (hereafter referred to as KO mice).
Using a fluorescence reporter-based strategy, we demonstrated
that ARR2PB-Cre mediates homologous recombination in both
luminal and basal epithelial cells in the prostate (Figure S1A
available online). Expression of Rbp-j in KO mouse prostates
was decreased by half as determined by qRT-PCR (Figure 2A).
Genomic analyses of the floxed exon 6 ofRbp-j revealed approx-
imately 30% deletion in both basal and luminal lineages (Fig-
ure 2B). Consistently, qRT-PCR analyses also confirmed a
65% and 96% decrease in Rbp-j transcript in FACS-sorted KO
prostate basal cells and in prostate spheres derived from KO
mouse prostate basal cells, respectively (Figure 2C). Collec-
tively, these data demonstrate that Rbp-j was deleted in both
the prostate basal and luminal cell lineages.
No defects in morphogenesis, lineage composition, or cellular
turnover were observed in adult KO mice, suggesting that RBP-
J-mediated canonical Notch signaling is dispensable for the
maintenance of prostate epithelial homeostasis (Figures 2D,
S1B and S1C). We then investigated whether Notch regulates
lineage proliferation and differentiation during tissue regenera-
tion. To induce extensive cellular turnover in the prostate,
androgen was deprived and replaced for two cycles in adult
WT and KOmice as described in the Supplemental Experimental
Procedures. KO mouse prostates were able to involute and
regenerate similarly to WT prostates in response to fluctuating
serum testosterone levels, suggesting that RBP-J-mediated
Notch signaling is not essential for the regenerative capacity of
prostate epithelia (Figure S1D). Alternatively, recombination-
escaped cells may be sufficient to maintain the homeostasis
and the regenerative potential of KO prostates.
However, we observed a 1.5- to 2-fold increase in the number
of K5+ or P63+ basal cells in the KOmice (Figure 2E). This expan-
sion in basal cells is due to an increase in proliferation as
measured by Ki67 (Figures 2F and 2G), and not a decrease in
apoptosis (data not shown). In contrast, there is only a slight,
but not statistically significant, increase in proliferation in the
P63 cells (Figure 2F). This minor increase is probably due toStem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Inc. 677
Figure 1. Expression of Notch Signaling Components in Prostate Epithelia
(A) FACS plot of prostate lineage fractionation. Prostate basal, luminal, and stromal cells are LinSca-1+CD49fHi, LinSca-1CD49fLow, and LinScaI+CD49f,
respectively.
(B) qRT-PCR analysis of markers for basal (P63), luminal (Nkx3.1), and stromal (Vimentin) cells in FACS-sorted prostate cell lineages.
(C) Expression of Notch signaling components in prostate basal and luminal cell lineages.
Data represent means and SD from three independent experiments. *p < 0.05.
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change in proliferation is observed in the nonbasal cells when
cytokeratin14 (K14), another more inclusive basal cell marker,
was used in the analysis (Figure 2G). Taken together these
data demonstrate that, in the absence of canonical Notch sig-
naling, basal cells overproliferate during prostate regeneration.
Loss of Notch Signaling Results in Large Hyperbudded
Spheres
We employed an in vitro prostate sphere assay (Xin et al., 2007)
to further investigate how Notch signaling regulates basal cell
proliferation and differentiation. FACS isolated adult murine
prostate basal cells were cultured in the prostate sphere
assay with or without N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-
phenyl]glycine-1,1-dimethylethyl ester (DAPT), an inhibitor of
the g-Secretase complex. DAPT effectively suppressed the
generation of NICD and the expression of Notch downstream
targets Hes1 and Hey1 in prostate sphere cells (Figures 3A and
3B). Higher concentrations of DAPT are not able to further
decrease NICD formation, suggesting that this reduction may
be maximal for this assay (Figure S2A). Spheres treated with678 Cell Stem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier InDAPT are larger and appear hyperbudded (Figure 3C and Fig-
ure S2B) (Shahi et al., 2011). In addition, prostate cells from
RBP-J KO animals (Figure 3D) and prostate cells expressing a
dominant-negative mastermind-like protein (dnMAML) (Maillard
et al., 2008) that blocks Notch signaling (Figures 3E and S2C)
both show a similar sphere phenotype, confirming that the large
hyperbudded phenotype is due to the suppression of Notch and
not other DAPT targets. Lastly, overexpressing NICD in prostate
spheres suppressed the DAPT-induced phenotype (Figures 3F
and S2D). Collectively, these results suggest that the large
hyperbudding phenotype is a direct consequence of inhibition
of Notch signaling.
Suppressing Notch Signaling Increases the Proliferation
of Prostate Basal Cells
Gene expression profiling of prostate spheres reveals that the
cell cycle gene ontology group is significantly altered between
vehicle- and DAPT-treated prostate spheres, of which several
major targets were verified by qRT-PCR (Figures 4A, 4B,
and S3A). Cell cycle analysis confirmed that cells treated with
DAPT were enriched in S and G2/M phases compared to thec.
Figure 2. Loss of Notch Signaling Induces Basal Cell Expansion during Regeneration
(A) Analysis of Rbp-j transcript in WT and KO prostate by qRT-PCR.
(B) Quantitative PCR analysis of the floxed exon 6 of Rbp-j in FACS-sorted basal and luminal cells of KO mice.
(C) Analysis of Rbp-j transcript in FACS-sorted basal cells from WT and KO mice or from basal-cell-derived prostate spheres.
(D) Transillumination images of urogenital organs and H&E staining of prostates from WT and KO mice.
(E–G) Immunohistochemical analyses of K5 and P63 (E), Ki67 and P63 (F), and Ki67 and K14 (G) inWT and KOmouse prostates that have undergone two cycles of
involution-regeneration.
Bar graphs show quantifications. Data represent means and SD from two experiments per group (A–C) or three mice in each group (E–G). *p < 0.05. See also
Figure S1.
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Notch Suppresses Prostate Basal Stem Cell Activityvehicle control (Figure 4C). To investigate the biological conse-
quence of Notch activation in prostate basal cells in vivo, we
bred ARR2PB-Cre mice with ROSA(N1IC) transgenic mice
(Stanger et al., 2005) to express the constitutively active Notch1
intracellular domain in prostate epithelium (Figure S3B). As
shown in Figure 4D, while Notch activation induces a hyper-
plastic growth of luminal cells, the number of basal cells is
decreased, as quantified by FACS analysis in Figure 4E. Ectopic
expression of NICD in FACS isolated adult mouse prostate basal
cells by lentiviral infection did not induce their luminal differenti-
ation (Figure S3C). This suggests that the skewed lineage
composition in the ARR2PB-ROSA(N1IC) model is not due to
a luminal fate bias of prostate stem cells by Notch activation.CellInstead, it suggests that Notch activation elicits distinctive
growth outcomes in prostate basal and luminal cell lineages.
Taken together these data suggest that Notch signaling
negatively regulates the proliferation of prostate basal cells.
Loss of Notch Signaling Inhibits Basal Stem Cell
Differentiation
Cells in the outermost layers of prostate spheres express P63,
possess a higher replating capacity, and represent more primi-
tive progenitor cells (Xin et al., 2007). Surprisingly, DAPT-treated
spheres express P63 throughout the entirety of the sphere (Fig-
ure 5A). We reasoned that inhibiting Notch signaling in prostate
spheres not only increases their proliferation, but also attenuatesStem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Inc. 679
Figure 3. Loss of Notch Signaling Results in Large Hyperbudded Spheres
(A) Western blot analysis of Notch intracellular domain (NICD) in vehicle- and DAPT-treated prostate spheres.
(B) qRT-PCR analysis of Hes1 and Hey1 expression in prostate spheres in response to DAPT.
(C–E) Transillumination images of DMSO vehicle- and DAPT-treated prostate spheres (C), prostate spheres derived fromWT and RBP-J KOmouse cells (D), and
prostate spheres expressing GFP and dnMAML (E).
(F) NICD overexpression suppresses DAPT-induced hyperbudding phenotype.
Bar graphs show quantifications. Data represent means and SD from two experiments per group. *p < 0.05. See also Figure S2.
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Ar, two markers for differentiation, were markedly decreased in
the DAPT-treated spheres (Figure 5B). Di-hydro-testosterone
(DHT) has been shown to further induce differentiation of pros-
tate sphere cells (Xin et al., 2007). DHT induces dilation of the
sphere lumen, resulting in morphologically hollow prostate
spheres (Figure 5C). In addition, while in DHT-free prostate
sphere culture most spheres are composed predominantly of
K5+K8 cells (type I), DHT increases the proportion of spheres
that consist of nests of K5K8+ cells in the center (type II) or
spheres that are mainly composed of K5K8+ cells (type III) (Fig-
ure 5D). DAPT treatment effectively suppresses the formation of
DHT-induced lumen formation and the formation of type II and III
spheres (Figures 5C and 5D). These results suggest that inhibit-
ing Notch signaling suppresses the differentiation of prostate
basal stem/progenitor cells.
We then performed serial passaging experiments to func-
tionally test whether inhibition of Notch signaling would in-
crease the percentage of progenitor cells in prostate spheres.
Treating dissociated primary prostate epithelial cells with DAPT
did not increase the sphere-forming unit, indicating that DAPT680 Cell Stem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Intreatment per se does not confer sphere-forming activity (Fig-
ure 5E). No significant differences in biology were noticed
when higher concentrations of DAPT were used (Figure S4).
The control and DAPT-treated primary spheres were then
dissociated and passaged in bulk in the absence of DAPT.
DAPT-treated spheres generated more secondary spheres
compared to the control spheres, suggesting that there are
more sphere-forming cells in the DAPT-treated primary culture
(Figure 5F). We also dissociated single spheres and passaged
them separately and found that the average sphere-forming
unit within single DAPT-treated spheres is approximately
3-fold higher than that of the control spheres (Figure 5G).
These results demonstrate that ablating Notch activity results
in the expansion of sphere-forming progenitor cells. Finally,
FACS sorted prostate basal cells from WT and RBP-J KO
mice were mixed with UGS mesenchyme and injected subcu-
taneously into SCID mice to regenerate prostatic tissues (Xin
et al., 2003). The KO basal cells formed prostate glands con-
taining more K5+ cells (Figure 5H), further corroborating that
Notch ablation induces expansion of basal cells in vivo during
regeneration.c.
Figure 4. Suppressing Notch Signaling Increases the Proliferation of Prostate Basal Cells
(A) Heatmaps from microarray data show that DAPT treatment increases expression of genes promoting cell cycle and represses CDKIs.
(B) Validation of expression changes of several representative genes in microarray analysis by qRT-PCR.
(C) FACS plots of cell cycle analysis for DMSO vehicle- and DAPT-treated prostate sphere cells. Bar graphs show quantifications. Data represent means and SD
from two independent experiments. *p < 0.05.
(D) Images of anterior and ventral prostate of ROSA(N1IC) and ARR2PB-ROSA(N1IC) mice stained with K5 (red) and K8 (green) antibodies. Note the decrease in
K5+ cells in the ARR2PB-ROSA(N1IC) model.
(E) FACS plots for analysis of lineage composition in ROSA(N1IC) and ARR2PB-ROSA(N1IC) mice. Data represent means and SD from four mice in each group.
*p < 0.05.
See also Figure S3.
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TGFb-Induced Cytostasis
Because Notch ablation only induced prostate basal cell prolifer-
ation when basal cells were cultured alone in vitro or when they
underwent regeneration due to changes in their environmental
cues, we reasoned that Notch coordinates with signaling medi-
ated by prostate stromal cells to regulate basal cell homeostasis.
Our expression microarray data show that the TGFb signaling
pathway ontology group is significantly downregulated in the
DAPT-treated group, which was verified by qRT-PCR (Figures
6A, 6B, and S5A). TGFb signaling plays a critical role in prostate
epithelial quiescence (Salm et al., 2005) and its signaling strength
is negatively regulated by androgen (Nantermet et al., 2004).CellAdditionally, Notch and TGFb signaling have been shown to
interact in regulating cellular quiescence in a variety of tissues
(Blokzijl et al., 2003; Carlson et al., 2008; Niimi et al., 2007).
Therefore, we hypothesized that Notch and TGFb signaling coor-
dinate together in regulating prostate basal cell homeostasis.
Prostate sphere cells respond to TGFb since prostate basal
cells express both TgfbR1 and TgfbR2 (Figure S5B). We found
that both the Notch inhibitor DAPT and the TGFbR1 inhibitor
SB431542 caused the same hyperbudding phenotype in
prostate sphere culture (Figures 6C and S5C). No synergistic
effect was noticed when both inhibitors were used (Figure S5D).
These results imply that Notch and TGFb act together in a linear
pathway. DAPT-treated cells or RBP-J null cells are relativelyStem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Inc. 681
Figure 5. Loss of Notch Signaling Inhibits Differentiation
(A) Immunohistochemical analysis of P63 in control- and DAPT-treated prostate spheres.
(B) qRT-PCR analysis of PSCA and AR in spheres treated with DAPT and DMSO vehicle.
(C and D) Transillumination images of prostate spheres in the presence of DHT alone or DHT in combination with DAPT. Bar graphs showquantification of spheres
with hollow and solid morphologies. (D) Immunohistochemical analysis of K5 and K8 reveals three types of prostate spheres at different differentiation stages in
vehicle and DAPT-treated sphere culture. Bar graphs show quantification.
(E and F) Bar graphs show quantification of sphere-forming units in DMSO- and DAPT-treated primary (E) and secondary (F) sphere culture.
(G) Dot graph shows quantification of sphere-forming cells from single prostate spheres in DMSO- and DAPT-treated culture. Error bars in (B)–(G) represent
means and SD from two independent experiments. *p < 0.05.
(H) Immunohistochemical analysis of K5 and K8 in prostate tissues regenerated from WT and RBP-J KO prostate basal stem cells.
See also Figure S4.
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and 6E), suggesting that TGFb signaling acts upstream of Notch
signaling (Zavadil et al., 2004). Nevertheless, average sizes of KO
prostate spheres decrease in response to TGFb (Figure 6E),
which indicates that Notch is only one of the downstream effec-
tors of TGFb signaling, and that Notch inhibition is not sufficient
to abolish the TGFb-induced cytostatic program. This conclu-
sion is also supported by our observation that ablating canonical
Notch signaling in the prostate at physiological conditions does682 Cell Stem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Innot override the homeostatic program safeguarded by TGFb
(Figures 2D, S1B, and S1C).
To determine the molecular mechanism through which loss of
Notch attenuates TGFb-induced cytostasis, we evaluated the
expression of five CDKIs upregulated by TGFb (Niimi et al.,
2007) in control DMSO- and DAPT-treated prostate sphere cells.
Upregulation of p15, p16, p19, and p21 by TGFb requires activa-
tion of Notch signaling, while p27 and cMyc do not seem to be
affected (Figure 6F). Similar changes were obtained using WTc.
Figure 6. Notch Inhibition Attenuates, but Does Not Override, TGFb-Induced Cytostasis
(A) Heatmap from microarray analysis shows downregulation of genes involved in TGFb signaling.
(B) Validation of expression changes of several representative genes in microarray analysis by qRT-PCR.
(C) Inhibition of TGFb signaling by SB431542 produces spheres similar to those produced by DAPT treatment.
(D) Treatment of prostate spheres with TGFb leads to a reduction in size that can be partially blocked by DAPT.
(E) Sphere size is controlled by TGFb in a dose-dependent fashion. KO cells are relatively resistant to TGFb but also decrease in size in response to
increasing TGFb.
(F) qRT-PCR analysis shows that expression of multiple CDKIs is induced by treatment with TGFb, which can be blocked by DAPT.
(G) CDKI KO prostate spheres are differentially protected from the suppressive effects of TGFb.
(H) qRT-PCR shows that spheres treated with TGFb have increased expression of Jag1, Hes1, and Hey1, which can be suppressed by DAPT treatment.
(I) Smad4f/f prostate spheres infected with Cre adenovirus (AdCre) generate a heterogeneous mixture of spheres in response to TGFb as compared to cells
infected with the control empty adenovirus (AdEmpty), which is suppressed to sizes under 50 mm. Large spheres express lower levels of Smad4, Jag1,Hes1, and
Hey1 as determined by qRT-PCR.
(J) Jag1f/f prostate spheres treated with AdenoCre mimic Smad4f/f spheres treated with AdenoCre and display reduced Jag1 and Hes1.
Error bars represent means and SD from three independent experiments (B, E, F, and H) or two independent experiments (G, I, and J). *p < 0.05. See also
Figure S5.
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ure S5E). In order to determine the biological relevance of
CDKI upregulation, we performed prostate sphere assays using
four available CDKI KO mice. While the resistance to TGFb
signaling varied for prostate sphere cells from the different
CDKI KO mice, interestingly, it correlated with the qRT-PCR
data where p16, which was most strongly upregulated, was
also the most resistant KO line to TGFb signaling (Figure 6G).
TGFb has been shown to induce Jag1 expression in mammary
epithelial cells to activate downstream Notch signaling (ZavadilCellet al., 2004). As shown in Figures 6H and S5F, TGFb treatment
induces the expression of Jag1, Hes1, and Hey1, and this induc-
tion is suppressed by loss of Notch signaling. To determine
whether TGFb induces Jagged1 expression through SMAD4,
we infected prostate basal cells from Smad4fl/fl mice with Cre
adenovirus or the control empty adenovirus and evaluated their
responses to TGFb in the sphere culture. As shown in Figure 6I,
while the empty adenovirus-infected cells formed predominantly
small spheres with diameters less than 50 mm, the size of
spheres derived from Cre adenovirus-infected cells wasStem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Inc. 683
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adopted the same hyperbudded phenotype as those in the
DAPT-treated prostate sphere culture (Figure 6I). qRT-PCR anal-
ysis of size-fractionated prostate spheres revealed thatSmad4 is
expressed at lower levels in bigger spheres (>50 mm) compared
to smaller spheres (<50 mm). This result suggests that the hetero-
geneous sizes of prostate spheres reflect an incomplete infec-
tion of Smad4fl/fl cells by Cre adenovirus. The larger and smaller
spheres were mainly derived from Smad4fl/fl cells that were
infected and uninfected by Cre adenovirus, respectively. The
expression levels of Jag1 and downstream Notch signaling
targets are also decreased in bigger spheres, indicating that
SMAD4 plays a critical role in TGFb-induced Jag1 expression
(Figure 6I). Similarly, disrupting Jag1 expression by infecting
Jag1fl/fl mouse prostate basal cells with Cre adenovirus also
resulted in the formation of relatively bigger prostate spheres
despite the presence of TGFb (Figure 6J), demonstrating the
critical role of Jag1 in TGFb-induced cytostasis of prostate
sphere cells.
Notch Activation Mediates a Positive Feedback Loop
by Upregulating TGFb Ligands and Receptors
Notch activation has previously been shown to induce the
expression of Tgfb ligands, proposing a positive feedback loop
between TGFb and Notch signaling (Lee et al., 2007; Niranjan
et al., 2008). Our results showed that Notch inhibition mitigates
TGFb-mediated signaling strength (Figures 6A and 6B) and
biology (Figures 6D and 6E), possibly by abolishing this posi-
tive feedback. Additionally, overexpressing NICD in prostate
spheres enhances SMAD3 activation (Figure 7A). We reasoned
that treating prostate sphere cells with TGFb would lead to posi-
tive feedback by upregulation of TGFb signaling components
through activation of Notch. As shown in Figure 7B and Fig-
ure S6A, qRT-PCR analyses demonstrate that treating prostate
sphere cells with TGFb increases expression of not only Tgfb1,
but also additional components of the TGFb signaling pathway,
including Tgfb3, TgfbR1, and LTBPs. However, these inductions
were blocked in DAPT-treated cells where Notch signaling was
abolished (Figures 7B and S6A). Similar observations were
made using RBP-J KO cells, suggesting that the induction of
these TGFb signaling components is RBP-J dependent (Fig-
ure S6B). Western blot analysis further corroborated that DAPT
treatment suppresses the induction of TgfbR1 in prostate
spheres (Figure 7C). There are several RBP-J consensus binding
sites (G/CTGGGAA) (Zhao et al., 2006) in the TGFbR1 promoter
(Figure 7D). Chromatin immunoprecipitation (ChIP) analysis
using RWPE cells, a human prostate epithelial cell line, demon-
strates that NICD directly binds to two of these putative binding
sites closest to the translational start codon, corroborating that
TgfbR1 is a direct Notch target (Figure 7D). Additionally, a
luciferase reporter assay showed that Notch intracellular domain
enhances the transcriptional activity of a 3.5 kb fragment of
TgfbR1 promoter containing these two putative RBP-J binding
sites, and single-nucleotide mutations in these consensus sites
abolished reporter activity (Figures 7E and S6C). These data
demonstrate a positive feedback loop between Notch and
TGFb and suggest that Notch and TGFb are redundant pathways
that coordinate to safeguard basal cell homeostasis. To test
this hypothesis, we perturbed both pathways by treating WT684 Cell Stem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Inand Rbp-j KO mice with the TGFbR1 inhibitor 4-[4-(1,3-
benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide
(SB431542). While the percentage of basal cells in WT mouse
prostate epithelia did not change in response to SB431542,
the RBP-J null basal cells expanded by 2-fold (Figure 7F). These
results demonstrate that Notch serves not only as a downstream
effector but also an amplifier for the TGFb-induced cytostatic
program in basal cells, and that these pathways overlap to inhibit
basal cell proliferation in vivo (Figure 7G).
DISCUSSION
The Significance of a Homeostatic Prostate Basal Cell
Lineage
Our study revealed how Notch and TGFb cooperate to regulate
the homeostasis of the prostate basal cell lineage. This is impor-
tant because deregulation of the basal cell lineage is a critical
biological event during prostate cancer initiation and progres-
sion. A traditional view for the function of prostate basal cells is
that they serve as barriers to protect luminal cells from onco-
genic insults (El-Alfy et al., 2000). Loss of prostate basal cells
is a diagnostic marker for prostate cancer. Basal cell loss could
be partly due to suppression of proliferation by increased local
TGFb concentration during the progression of precancerous
lesions. Our study showed that Notch is important for basal cells
to aptly sense TGFb signaling strength. It is tempting to hypoth-
esize that suppressing Notch signaling may delay progression of
PIN lesions by sustaining an intact basal cell layer. Alternatively,
we recently demonstrated that prostate basal cells can also
serve as the cellular origin for prostate cancer, which requires
the differentiation of basal cells into luminal cells (Choi et al.,
2012). We showed here that although increased Notch activity
is not sufficient to promote differentiation of basal cells into
luminal cells, it does contribute to this process. Therefore, sup-
pressing Notch signaling may also delay initiation of prostate
cancer with a basal cell origin by inhibiting differentiation of basal
cells into luminal cells. In summary, regardless of the role of basal
cells in prostate cancer initiation, our study provides rationale for
suppressing prostate cancer progression by targeting Notch
signaling. Unfortunately, systemic and long-term Notch inhibi-
tion often causes intestinal toxicity and vascular neoplasms.
Therefore, defining molecular and cellular mechanisms that
dictate lineage-specific biological functions of Notch will inspire
novel therapeutic avenues to target Notch signaling in a more
cell-lineage-specific manner.
Basal cells are in direct contact with each other in prostate
spheres. In contrast, basal cells in mouse prostate are not
always closely associated with each other and tend to form a
punctuated layer. It has been shown that ligand/receptor cis-
interactions inhibit, rather than activate, Notch signaling (del
Alamo et al., 2011). Therefore, our conclusion from the in vitro
sphere assay that TGFb-induced cytostasis occurs partly
through upregulation of Jag1 may not always be extended to
the in vivo situation in mice. Nevertheless, human prostate basal
cells form a continuous layer and adjacent basal cells are always
in direct contact with each other. Therefore, our conclusions
derived from the prostate sphere system may be adapted well
in human prostate in vivo. Pertinent to this discussion, it has
been observed that human and mouse prostate basal cellsc.
Figure 7. Notch Activation Mediates a Positive Feedback Loop by Upregulating TGFb Ligands and Receptors
(A) Western blot shows that pSMAD3 expression is increased in prostate sphere cells overexpressing NICD.
(B) qRT-PCR shows that TGFb ligands and receptors are increased in response to exogenous TGFb. This induction can be suppressed by DAPT.
(C) Western blot shows that DAPT suppresses TGFb-upregulated TgfbR1. Bar graphs show quantifications.
(D) ChIP analysis of the TgfbR1 promoter demonstrates endogenous Notch binding at two RBP-J consensus sequences.
(E) Luciferase reporter containing TgfbR1 promoter region with two intact RBP-J binding sites is activated by NICD. Data in (A)–(E) represent means and SD from
two or three independent experiments. *p < 0.05.
(F) Immunohistochemical analysis of expression of K5 and K8 in anterior and ventral prostate lobes of WT and Rbp-j KO mice that have been treated with
SB431542 or the control DMSO vehicle. Bar graphs show quantification. Data represent means and SD from two or three independent mice in each group.
*p < 0.05.
(G) Schematic illustration of the reciprocal positive regulatory loop between TGFb and Notch in prostate epithelia.
See also Figure S6.
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proliferation indices. Therefore, it should be noted that not all
conclusions derived from murine cells will apply to human cells.
The Role of the Reciprocal Regulatory Loop between
Notch and TGFb in Prostate Epithelial Homeostasis
Crosstalk between Notch and TGFb has been extensively
studied in many organ systems (Blokzijl et al., 2003; Carlson
et al., 2008; Lee et al., 2007; Niimi et al., 2007; Zavadil et al.,
2004). Our study not only corroborated some of these findings,
but also identified additional interactions between Notch and
TGFb in the prostate. Notch signaling acts downstream of theCellTGFb program and is partially responsible for inhibiting prolifer-
ation of prostate basal cells. Furthermore, Notch signaling posi-
tively regulates multiple members of the TGFb family and allows
it to amplify the TGFb-mediated cytostatic program by a positive
feedback mechanism. Specifically, we identified TgfbR1 as
a direct Notch target. Our findings suggest that this positive
feedback loop increases the sensitivity of prostate basal cells
to respond to TGFb stimulation promptly, and fortifies the cyto-
static effect of TGFb signaling to balance the stimulatory
signaling mediated by growth factors to safeguard basal cell
homeostasis (Figure 7G). This model nicely explains why a
distinctive proliferating phenotype of the RBP-J KO prostateStem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier Inc. 685
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TGFb signaling is also diminished (Figures 2E–2G) or inhibited
(Figure 7F). In the sphere assay, TGFb concentration is lower
than that in vivo due to the absence of prostate stromal cells,
which are major sources of active TGFbs in vivo (Figure S5B);
in the castration-regeneration model, expression of TGFb in
the prostate is significantly reduced when androgen is replaced
in castrated mice (Nantermet et al., 2004).
Paradoxically, in the muscle where TGFb also promotes stem
cell quiescence, Notch activation has an opposing role and can
reverse this pathway, allowing myoblasts to proliferate and
regenerate (Carlson et al., 2008). This suggests that the func-
tional outcome of the interaction between Notch and TGFb is
tissue context dependent, which is in agreement with the fact
that both SMADs and the Notch/RBP-J complex are promis-
cuous in joining with other complexes and are recruited to
distinct genomic loci under different cellular contexts (Blokzijl
et al., 2003). This may partially account for the tissue-dependent
regulation of self-renewal of stem cells by Notch. Notch activa-
tion increases the self-renewal capacity of hematopoietic,
neural, and muscle stem cells, but induces differentiation of
epithelial stem cells in skin, breast, lung, and thymic epithelia.
A common feature of these epithelial stem cells and the prostate
basal stem cells is that they all express P63, a transcription factor
that maintains the proliferative potential of epithelial stem cells
(Mills et al., 1999). Interestingly, P63 is negatively regulated by
Notch at the transcriptional level through the interferon signaling
pathway (Nguyen et al., 2006). In addition, P63 functionally
antagonizes TGFb during the epithelial-mesenchymal transition
(Adorno et al., 2009). These facts suggest that the balance
between the signaling mediated by P63, Notch, and TGFb can
be a major determinant for the overall biological outcome in
those epithelial systems.
The Multifaceted Functions of Notch in Different
Prostate Epithelial Lineages
Our study also revealed distinctive biological consequences of
Notch activation in the prostate basal and luminal cell lineages.
While Notch activation suppresses prostate basal cells, it
induces proliferation in the luminal cell lineage. This cellular-
context-dependent biological function of Notch is conserved in
the mammary gland. The mammary gland myoepithelial cells
are anatomically and functionally reminiscent of the prostate
basal cells. Suppressing Notch signaling in myoepithelial cells
leads to their expansion, while ectopically activating Notch
signaling in luminal cells results in hyperplastic growth (Bouras
et al., 2008; Buono et al., 2006). Interestingly, Notch activation
in mammary repopulating stem cells drives their commitment
toward the luminal cell lineage (Bouras et al., 2008). This conclu-
sion does not seem to directly carry over to the prostate. We
showed that ectopic expression of NICD is not sufficient to
induce differentiation of prostate basal cells into luminal cells
(Figure S3C). This is also consistent with our previous study
showing that adult prostate basal and luminal cell lineages are
mainly self-sustained independently (Choi et al., 2012). However,
in vitro Notch plays a partial role during DHT-mediated differen-
tiation. In conclusion, our study demonstrated clearly that Notch
activation confers distinct growth outcomes in the prostate basal
and luminal cell lineages, but does not support a major role for686 Cell Stem Cell 11, 676–688, November 2, 2012 ª2012 Elsevier InNotch in cell fate choice for adult prostate basal stem cells in vivo
and in vitro.
Though luminal cells express relatively high levels of Notch
receptors, the machinery for Notch activation, and its down-
stream targets, we did not detect any changes in luminal cell
biology when the Notch pathway was ablated. This result
suggests that the contribution of Notch/RBP-J signaling to pros-
tate luminal development is completed before the activation of
the probasin promoter. It is possible that Notch is only activated
in a small fraction of adult luminal cells, some of which have
escaped homologous recombination mediated by ARR2PB-
Cre. The recombination-escaped cell population may be suffi-
cient to maintain luminal epithelial homeostasis. Alternatively,
RBP-J-independent noncanonical Notch signaling (Heitzler,
2010) is still intact in the KO mice and may play an even more
crucial, yet unknown, role in prostate homeostasis.
It was previously reported that human prostate transit-
amplifying basal cells require Notch for their survival when
cultured in low calcium medium in 2D culture (Litvinov et al.,
2006). We found here that Notch is not essential for the survival
of basal cells. These different results could be due to experi-
mental conditions such as our 3D culture inside Matrigel with
a high concentration of calcium, or transplantation in vivo.
Under these experimental conditions, signals provided by
growth factors in Matrigel in vitro or in basement membrane
in vivo may be redundant to Notch-mediated survival signaling,
hence making Notch dispensable for survival. On the other
hand, these previous studies suggested that calcium-induced,
E-Cadherin-mediated interaction between transit-amplifying
cells activates Notch signaling and promotes cell differentiation,
which is in agreement with our conclusion that Notch activa-
tion suppresses prostate basal cell proliferation and induces
differentiation.
Finally, Wu et al. recently also activated Notch signaling in the
prostate using a PB-Cre4 model (Wu et al., 2011). Paradoxically,
they observed an expansion of not only the luminal but also the
basal cells. The potential mechanisms underlying the distinct
phenotypes between the two studies are unknown. It is possible
that the PB-Cre4 mouse model possesses higher stromal Notch
signaling due to leaky activation of the PB promoter in the
stromal layer (Wu et al., 2011), which indirectly confers survival
and proliferative potential to basal cells.
EXPERIMENTAL PROCEDURES
Mouse Strains and Procedures
The sources of experimental mice and the genotyping strategies are described
in the Supplemental Experimental Procedures. Castration, androgen re-
placement, dissociation of prostate, prostate sphere assay, and prostate
regeneration assay were performed using standard techniques described
previously (Xin et al., 2005, 2007). All of the mice were housed and bred under
the regulation of The Center for Comparative Medicine at the Baylor College of
Medicine.
Superarray and Expression Microarray
Analysis of Notch pathwaymembers was performed on RT2 Profiler PCRArray
Mouse Notch Signaling Pathway plates following the manufacturer’s instruc-
tions (SABiosciences, Frederick, MD). Expression microarray assays were
performed using 4x44K Whole Mouse Genome Oligo Microarray chip (Agilent
Technologies, Santa Clara, CA), and the Feature Extraction Software v9.1.3.1
(Agilent Technologies) was used to extract and analyze the signals.c.
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The g-Secretase inhibitor DAPT (Tocris Bioscience, Ellisville, MO) and the
TgfbR antagonist SB431542 (Tocris Bioscience, Ellisville, MO) were dissolved
in DMSO and used at a concentration of 5mM and 10mM in vitro, respectively.
Cell culture media were replaced every 24 hr. For mouse studies, SB431542
(10 mg/kg) or vehicle (DMSO) was injected i.p. every 24 hr for 10 days.
Recombinant TGFb (R&D Systems, Minneapolis, MN) was reconstituted at
10 mg/ml in sterile 4mM HCl with 0.1% BSA and stored at 80C.
Western Blot, Histology, and IHC Analyses
Quantification of Western blots was performed by Odyssey infrared imaging
system (Li-Cor Biosciences) or traditional chemiluminescent imagers. Paraffin
embedded sections were stained and counterstained with 4,6-diamidino-2-
phenylindole (DAPI) (Sigma-Aldrich, St. Louis, MO). Secondary antibodies
were labeled with Alexa Fluro 488 or 594 (Invitrogen, Carlsbad, CA). Immuno-
fluorescence staining was imaged using an Olympus BX60 fluorescence
microscope or a Leica EL6000 confocal microscope. Cell counting was per-
formed either manually or via ImagePro Software.
ChIP Assay and TGFbR1 Promoter Reporter Assay
The ChIP was performed using the ChIP-IT Express kit (ActiveMotif, Carlsbad,
CA).The luciferase reporter assay was performed using a 3.5 kb genomic
sequence upstream of the transcriptional start codon of the human TGFbR1.
The procedures are described in detail in the Supplemental Experimental
Procedures.
Statistics
All experiments were performed using 2–10 mice in independent experiments.
Data are presented as mean ± SD. Student’s t test was used to determine
significance between groups. For all statistical tests, the 0.05 level of
confidence was accepted for statistical significance.
ACCESSION NUMBERS
Array data have been deposited on GEO (GSE34067).
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes six figures and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2012.07.003.
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